نتائج البحث - "Peter, Rossing"

المساهمون: Bordeaux population health (BPH), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), CAMM - Research Program for Clinical and Molecular Metabolism, HUS Abdominal Center, Nefrologian yksikkö, Research Programs Unit, Clinicum, Medicum, Department of Medicine, Per Henrik Groop / Principal Investigator

المصدر: Journal of the American Society of Nephrology
Journal of the American Society of Nephrology, American Society of Nephrology, 2021, 32 (10), pp.2634-2651. ⟨10.1681/ASN.2020101457⟩

مصطلحات موضوعية: Gene-based tests, GENES, GENETICS, NEPHROPATHY, DURATION, 030209 endocrinology & metabolism, Hydroxysteroid 17-beta dehydrogenase 14, Diabetic nephropathy, Biology, 03 medical and health sciences, 0302 clinical medicine, Gene expression, medicine, Coding region, GENOME-WIDE ASSOCIATION, Diabetic kidney disease, PREDICTORS, Gene, Exome, 030304 developmental biology, RISK, 0303 health sciences, Type 1 diabetes, Kidney, COMPLICATIONS, End stage kidney disease, MICROALBUMINURIA, Rare variants, General Medicine, medicine.disease, RENAL DECLINE, medicine.anatomical_structure, Nephrology, 3121 General medicine, internal medicine and other clinical medicine, Cancer research, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Kidney disease

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1d8ebafcd82a8106854f67bac0a578dTest
http://hdl.handle.net/20.500.12278/123983Test

7

Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3-deoxyglucosone in participants with type 2 diabetes and microalbuminuria

المؤلفون: M.M.J. van Greevenbroek, Nordin M J Hanssen, Casper G. Schalkwijk, M Piazza, M. P. H. van de Waarenburg, Frederik Persson, P Hovind, H. H. Parving, Peter Rossing, Jean L.J.M. Scheijen, Coen D.A. Stehouwer

المساهمون: RS: Carim - V01 Vascular complications of diabetes and metabolic syndrome, Interne Geneeskunde, MUMC+: MA Alg Onderzoek Interne Geneeskunde (9), MUMC+: HVC Pieken Maastricht Studie (9), MUMC+: MA Interne Geneeskunde (3), MUMC+: Centrum voor Chronische Zieken (3), MUMC+: MA Med Staf Artsass Interne Geneeskunde (9), MUMC+: MA Endocrinologie (9), MUMC+: MA Maag Darm Lever (9), MUMC+: MA Hematologie (9), MUMC+: MA Medische Oncologie (9), MUMC+: MA Nefrologie (9), MUMC+: MA Reumatologie (9), Vascular Medicine, ACS - Diabetes & metabolism, ACS - Atherosclerosis & ischemic syndromes, Amsterdam Gastroenterology Endocrinology Metabolism

المصدر: Diabetic Medicine
Diabetic Medicine, 38(9):14405. Wiley
Piazza, M, Hanssen, N M J, Persson, F, Scheijen, J L, van de Waarenburg, M P H, van Greevenbroek, M M J, Rossing, P, Hovind, P, Stehouwer, C D A, Parving, H H & Schalkwijk, C G 2021, ' Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3-deoxyglucosone in participants with type 2 diabetes and microalbuminuria : An IRMA2 sub-study ', Diabetic Medicine, vol. 38, no. 9, e14405 . https://doi.org/10.1111/dme.14405Test
Diabetic medicine, 38(9):e14405. Wiley-Blackwell

مصطلحات موضوعية: Male, Time Factors, Endocrinology, Diabetes and Metabolism, Type 2 diabetes, urologic and male genital diseases, chemistry.chemical_compound, 0302 clinical medicine, Endocrinology, Glycation, Tandem Mass Spectrometry, 030212 general & internal medicine, Methylglyoxal, Glyoxal, Research: Treatment, Middle Aged, Pyruvaldehyde, female genital diseases and pregnancy complications, RENIN-ANGIOTENSIN SYSTEM, Treatment Outcome, 3-Deoxyglucosone, Female, GLYCATION END-PRODUCTS, medicine.drug, medicine.medical_specialty, NEPHROPATHY, 030209 endocrinology & metabolism, Deoxyglucose, Nephropathy, 03 medical and health sciences, Irbesartan, Double-Blind Method, Internal medicine, Diabetes mellitus, Internal Medicine, medicine, Albuminuria, Humans, business.industry, medicine.disease, INDIVIDUALS, PATHOLOGY, chemistry, Diabetes Mellitus, Type 2, Microalbuminuria, business, Angiotensin II Type 1 Receptor Blockers, Biomarkers, Chromatography, Liquid, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33f74f5aacf5447d51e40b7a9ad1d685Test
https://doi.org/10.1111/dme.14405Test

8

Mineralocorticoid Receptor Antagonists for Diabetic Kidney Disease

المؤلفون: Peter Rossing

المصدر: Clin J Am Soc Nephrol

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::510fbbe6e0a4eb5c1334408354869a16Test
https://doi.org/10.2215/cjn.16201020Test

9

The effect of liraglutide and sitagliptin on oxidative stress in persons with type 2 diabetes

المؤلفون: Mark M. Smits, Emil List Larsen, Emilie H. Zobel, Daniël H. van Raalte, Bernt Johan von Scholten, Lennart Tonneijck, Suvanjaa Sivalingam, Tine W. Hansen, Marcel H. A. Muskiet, Jaap A. Joles, Frederik Persson, Lars Jorge Diaz, Henrik E. Poulsen, Trine Henriksen, Peter Rossing

المساهمون: Internal medicine, ACS - Diabetes & metabolism, Amsterdam Gastroenterology Endocrinology Metabolism, General practice

المصدر: Scientific Reports
Scientific Reports, 11(1):10624. Nature Publishing Group
Sivalingam, S, Larsen, E L, van Raalte, D H, Muskiet, M H A, Smits, M M, Tonneijck, L, Joles, J A, von Scholten, B J, Zobel, E H, Persson, F, Henriksen, T, Diaz, L J, Hansen, T W, Poulsen, H E & Rossing, P 2021, ' The effect of liraglutide and sitagliptin on oxidative stress in persons with type 2 diabetes ', Scientific Reports, vol. 11, no. 1, 10624 . https://doi.org/10.1038/s41598-021-90191-wTest
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3a754cc228dea7ca5adfeaed315e3efTest
http://europepmc.org/articles/PMC8134438Test

10

Beneficial impact of intensified multifactorial intervention on risk of stroke: outcome of 21 years of follow-up in the randomised Steno-2 Study

المؤلفون: Oluf Pedersen, Peter Rossing, Hans-Henrik Parving, Jens Oellgaard, Peter Gæde, Christina Kruuse

المصدر: Diabetologia
Gæde, P, Oellgaard, J, Kruuse, C, Rossing, P, Parving, H-H & Pedersen, O 2019, ' Beneficial impact of intensified multifactorial intervention on risk of stroke: outcome of 21 years of follow-up in the randomised Steno-2 Study ', Diabetologia, vol. 62, no. 9, pp. 1575-1580 . https://doi.org/10.1007/s00125-019-4920-3Test
Gæde, P, Oellgaard, J, Kruuse, C, Rossing, P, Parving, H H & Pedersen, O 2019, ' Beneficial impact of intensified multifactorial intervention on risk of stroke : outcome of 21 years of follow-up in the randomised Steno-2 Study ', Diabetologia, vol. 62, no. 9, pp. 1575-1580 . https://doi.org/10.1007/s00125-019-4920-3Test

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68569bf2eb079e57fbaeab7f696fcb83Test
http://europepmc.org/articles/PMC6677690Test

تنقيح النتائج